V. Wunderlich

666 total citations
46 papers, 465 citations indexed

About

V. Wunderlich is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, V. Wunderlich has authored 46 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Immunology and 11 papers in Genetics. Recurrent topics in V. Wunderlich's work include HIV Research and Treatment (9 papers), Virus-based gene therapy research (8 papers) and T-cell and Retrovirus Studies (5 papers). V. Wunderlich is often cited by papers focused on HIV Research and Treatment (9 papers), Virus-based gene therapy research (8 papers) and T-cell and Retrovirus Studies (5 papers). V. Wunderlich collaborates with scholars based in Germany, Belgium and United States. V. Wunderlich's co-authors include A Graffi, Michael Böttger, Ulrike Stein, Wolfgang Uckert, Wolfgang Walther, Joachim Denner, Wolfgang Haensch, Fey F, Hans Krause and Burkhard Jandrig and has published in prestigious journals such as International Journal of Cancer, Virology and European Journal of Cancer.

In The Last Decade

V. Wunderlich

37 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Wunderlich Germany 11 233 95 75 69 61 46 465
Robert Buckland United Kingdom 12 248 1.1× 48 0.5× 48 0.6× 23 0.3× 51 0.8× 19 545
E Xiaofei United States 14 337 1.4× 127 1.3× 117 1.6× 41 0.6× 43 0.7× 22 837
Tamim Salehzada France 18 558 2.4× 193 2.0× 337 4.5× 72 1.0× 55 0.9× 26 981
Theodore A. Bremner United States 11 346 1.5× 71 0.7× 125 1.7× 23 0.3× 43 0.7× 20 574
J.J. Maio United States 14 317 1.4× 27 0.3× 36 0.5× 60 0.9× 45 0.7× 17 435
Kuang-Dong Wuu Taiwan 12 190 0.8× 44 0.5× 46 0.6× 12 0.2× 91 1.5× 26 478
Mathias Platzer Germany 6 112 0.5× 47 0.5× 166 2.2× 11 0.2× 40 0.7× 6 428
Paul Theodorakis United States 6 266 1.1× 88 0.9× 55 0.7× 21 0.3× 50 0.8× 7 398
Drew Sullivan United States 7 352 1.5× 28 0.3× 26 0.3× 32 0.5× 19 0.3× 11 525
Maria G. Santagati Finland 8 170 0.7× 31 0.3× 81 1.1× 21 0.3× 26 0.4× 9 377

Countries citing papers authored by V. Wunderlich

Since Specialization
Citations

This map shows the geographic impact of V. Wunderlich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Wunderlich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Wunderlich more than expected).

Fields of papers citing papers by V. Wunderlich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Wunderlich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Wunderlich. The network helps show where V. Wunderlich may publish in the future.

Co-authorship network of co-authors of V. Wunderlich

This figure shows the co-authorship network connecting the top 25 collaborators of V. Wunderlich. A scholar is included among the top collaborators of V. Wunderlich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Wunderlich. V. Wunderlich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wunderlich, V.. (2020). 50 Jahre Reverse Transkriptase. BIOspektrum. 26(3). 343–344.
2.
3.
Wunderlich, V.. (2007). „Zur Selbstreproduktion befähigte Substanzen“ als zelluläre Angriffsorte chemischer Cancerogene. NTM Zeitschrift für Geschichte der Wissenschaften Technik und Medizin. 15(4). 271–283. 1 indexed citations
4.
Schenk, Jörg A., et al.. (2000). Reverse transformation of human mammary carcinoma cells.. PubMed. 19(6B). 5119–25. 1 indexed citations
5.
Wunderlich, V., et al.. (1994). Effects of tamoxifen, droloxifene and 17β-estradiol on Rauscher mouse leukemogenesis. Cancer Letters. 82(1). 89–94. 1 indexed citations
6.
Stein, Ulrike, Wolfgang Walther, & V. Wunderlich. (1994). Point mutations in the mdr1 promoter of human osteosarcomas are associated with In vitro responsiveness to multidrug resistance relevant drugs. European Journal of Cancer. 30(10). 1541–1545. 41 indexed citations
7.
Jandrig, Burkhard & V. Wunderlich. (1992). Membrane transport in multidrug resistance, development, and disease. Journal of Cancer Research and Clinical Oncology. 118(3). 238–239. 8 indexed citations
8.
Krause, Hans, V. Wunderlich, & Wolfgang Uckert. (1989). Molecular cloning of a type D retrovirus from human cells (PMFV) and its homology to simian acquired immunodeficiency type D retroviruses. Virology. 173(1). 214–222. 12 indexed citations
9.
10.
Denner, Joachim, et al.. (1985). Suppression of human lymphocyte mitogen response by retroviruses of type D. Archives of Virology. 86(3-4). 177–186. 10 indexed citations
11.
Uckert, Wolfgang, V. Wunderlich, Jacques Ghysdael, Daniel Portetelle, & Arsène Burny. (1984). Bovine leukemia virus (BLV)—A structural model based on chemical crosslinking studies. Virology. 133(2). 386–392. 13 indexed citations
12.
Wunderlich, V., et al.. (1982). Tumor promoter-stimulated synthesis of Mason-Pfizer monkey virus. Journal of Cancer Research and Clinical Oncology. 102(3). 271–275. 2 indexed citations
13.
Wunderlich, V., et al.. (1982). Disintegration of retroviruses by chelating agents. Archives of Virology. 73(2). 171–183. 7 indexed citations
14.
Wunderlich, V. & Wolfgang Uckert. (1981). Type D retroviruses from human cells do not contain a minor glycoprotein shared by old world monkey type D viruses. Archives of Virology. 70(1). 43–53. 4 indexed citations
15.
Wunderlich, V., et al.. (1980). Antiviral effect of haloperidol on Rauscher murine leukemia virus.. PubMed. 50(8). 758–62. 21 indexed citations
16.
17.
Böttger, Michael & V. Wunderlich. (1973). Rat liver mitochondrial DNA: unexpected sedimentation behavior and evidence for a molecular heterogeneity.. PubMed. 31(5). 655–66. 1 indexed citations
18.
Wunderlich, V., et al.. (1972). Studies on nitrosodimethylamine: Preferential methylation of mitochondrial DNA in rats and hamsters. Chemico-Biological Interactions. 4(2). 81–89. 66 indexed citations
19.
Wunderlich, V., et al.. (1970). [Alkylation of nuclear DNA of various rat organs by nitrosomethyl urea in vivo].. PubMed. 35(3). 251–8. 2 indexed citations
20.
Böttger, Michael, et al.. (1968). [On the sedimentation behavior of mitochondrial DNA in stabilizing D2O gradients].. PubMed. 21(5). 587–93. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert Buckland Breakdown of academic impact, for papers by E Xiaofei Breakdown of academic impact, for papers by Tamim Salehzada Breakdown of academic impact, for papers by Theodore A. Bremner Breakdown of academic impact, for papers by J.J. Maio Breakdown of academic impact, for papers by Kuang-Dong Wuu Breakdown of academic impact, for papers by Mathias Platzer Breakdown of academic impact, for papers by Paul Theodorakis Breakdown of academic impact, for papers by Drew Sullivan Breakdown of academic impact, for papers by Maria G. Santagati
Rankless by CCL
2026